Filing Flows › Comparisons › MGNX vs ELTP
Macrogenics vs Elite Pharmaceuticals: MGNX and ELTP compared
Macrogenics is the larger company: $32.8M of revenue in its latest quarter (Q2 2026) against $32.4M for Elite Pharmaceuticals (Q1 FY27). Macrogenics is growing faster (+378% against -20% a year earlier). Elite Pharmaceuticals is more profitable, with an operating margin of 23.3% against -42.2%.
Where the money goes: MGNX and ELTP
Macrogenics (MGNX) · Q2 2026
Macrogenics, Q2 2026: revenue $32.8M (+378% year over year), operating margin -42.2%, net earnings $19.5M, operating cash flow −$40.7M. The chart follows the revenue to costs, profit and cash.
Elite Pharmaceuticals (ELTP) · Q1 FY27
Elite Pharmaceuticals, Q1 FY27: revenue $32.4M (-20% year over year), operating margin 23.3%, net earnings $5.9M, operating cash flow $10.1M. The chart follows the revenue to costs, profit and cash.
| Macrogenics (MGNX) | Elite Pharmaceuticals (ELTP) | |
|---|---|---|
| Latest quarter | Q2 2026 | Q1 FY27 |
| Revenue | $32.8M | $32.4M |
| Revenue growth, Y/Y | +378% | -20% |
| Gross margin | — | 41.7% |
| Operating margin | -42.2% | 23.3% |
| Net earnings | $19.5M | $5.9M |
| Net margin | 59.4% | 18.3% |
| Operating cash flow | −$40.7M | $10.1M |
| Free cash flow | — | $9.3M |
Where the revenue comes from
Macrogenics
- Collaborative and other agreements: $25.5M (78%)
- Royalty revenue: $7.3M (22%)
Elite Pharmaceuticals
- Abbreviated New Drug Applications Revenue: $32.1M (99%)
- Licensing: $221K (1%)
Questions
Which is bigger, Macrogenics or Elite Pharmaceuticals?
Macrogenics is the larger company: $32.8M of revenue in its latest quarter (Q2 2026) against $32.4M for Elite Pharmaceuticals (Q1 FY27).
Is Macrogenics or Elite Pharmaceuticals growing faster?
Macrogenics is growing faster (+378% against -20% a year earlier).
Which is more profitable, Macrogenics or Elite Pharmaceuticals?
Elite Pharmaceuticals is more profitable, with an operating margin of 23.3% against -42.2%.
More: Macrogenics earnings · how Macrogenics makes money · Elite Pharmaceuticals earnings · how Elite Pharmaceuticals makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Aug 14, 2026; 10-Q filed Aug 13, 2026). Fiscal quarters can end on different dates. Not investment advice.